Rossari Biotech Ltd: Stock Analysis & Fundamentals

Updated this week

Rossari Biotech Ltd (Seeds/Tissue Culture/Bio Technology) — fundamental analysis, earnings data, and key metrics. PE: 16.0. ROE: 12.2%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

📊Debt increased 62% YoY — leverage rising

🌐FII stake decreased 1.0% this quarter

Key Numbers

Current Price

₹398

Dividend Yield

0.13%

Market Cap

2.2K Cr

Valuation

N/A

← Back to Seeds/Tissue Culture/Bio Technology Dashboard

Frequently Asked Questions: Rossari Biotech Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Rossari Biotech Ltd's latest quarterly results?

Rossari Biotech Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: +3.1%
Revenue Growth YoY: +13.5%
Operating Margin: 12.0%

What is Rossari Biotech Ltd's current PE ratio?

Rossari Biotech Ltd's current PE ratio is 16.0x.

Current PE: 16.0x
Market Cap: 2.2K Cr
Dividend Yield: 0.13%

What is Rossari Biotech Ltd's price-to-book ratio?

Rossari Biotech Ltd's price-to-book ratio is 1.8x.

Price-to-Book (P/B): 1.8x
Book Value per Share: ₹226
Current Price: ₹398

Is Rossari Biotech Ltd a fundamentally strong company?

Rossari Biotech Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 16.0%

Is Rossari Biotech Ltd debt free?

Rossari Biotech Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹353 Cr

What is Rossari Biotech Ltd's return on equity (ROE) and ROCE?

Rossari Biotech Ltd's return ratios over recent years

FY2023: ROCE 18.0%
FY2024: ROCE 18.0%
FY2025: ROCE 16.0%

Is Rossari Biotech Ltd's cash flow positive?

Rossari Biotech Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹137 Cr
Free Cash Flow (FCF): ₹-46 Cr
CFO/PAT Ratio: 101% (strong cash conversion)

What is Rossari Biotech Ltd's dividend yield?

Rossari Biotech Ltd's current dividend yield is 0.13%.

Dividend Yield: 0.13%
Current Price: ₹398

Who holds Rossari Biotech Ltd shares — promoters, FII, DII?

Rossari Biotech Ltd's shareholding pattern (Dec 2025)

Promoters: 68.2%
FII (Foreign): 2.3%
DII (Domestic): 18.3%
Public: 11.3%

Is promoter holding increasing or decreasing in Rossari Biotech Ltd?

Rossari Biotech Ltd's promoter holding has decreased recently.

Current Promoter Holding: 68.2% (Dec 2025)
Previous Quarter: 68.2% (Sep 2025)
Change: -0.03% (decreasing — worth monitoring)

Is Rossari Biotech Ltd a new momentum entry or an established outperformer?

Rossari Biotech Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Rossari Biotech Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Rossari Biotech Ltd may be worth studying

Cash flow is positive — CFO ₹137 Cr

What is the investment thesis for Rossari Biotech Ltd?

Rossari Biotech Ltd investment thesis summary:

What is the future outlook for Rossari Biotech Ltd?

Rossari Biotech Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.